FDA commish contenders under final review at White House; Inside Eli Lilly’s massive dealmaking spree; Idaho mother charged ...

Naming challenges, combination trials and AI augmentation are forcing pharma brands to establish strategic differentiation ...

The FDA has proposed a new rule that would seek to eliminate the adequate provision guidance in pharma DTC ads.

The obesity rate falls as GLP-1s rise; DTC telehealth companies are prescribing GLP-1s at alarming rates; FDA approvals of ...

Spectrum Science, a 2026 MM+M Agency 100 honoree, is elevating chief commercial officer Marie Emms to president of its ...

The modern healthcare landscape is in an era where clinical innovation alone no longer guarantees market success. Instead, ...

The Hikma v. Amarin ruling brings clarity, but not new opportunities; White House adds pandemic response staff as Ebola cases ...

Patients seek solutions and trust, two elements that can be elusive. The leaders on this panel at Cannes highlighted how ...

A recent study pinpoints the two leading GLP-1 manufacturers as the top pharma companies cited the most across leading AI ...

RFK Jr. wants you to get more preventive care. Some experts say that's a bad idea; AI is expected to automate healthcare ...

Washington is alone in legally requiring such proactive outreach to the news media, the Federation of State Medical Boards ...

HCPs and patients don’t behave the way you buy. They are not disconnected groups. The leaders on this IQVIA Digital-hosted ...